These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1593 related articles for article (PubMed ID: 33978234)

  • 21. Immunological aspects of COVID-19-related skin manifestations: Revisiting pathogenic mechanism in the light of new evidence.
    Mahdiabadi S; Rajabi F; Tavakolpour S; Rezaei N
    Dermatol Ther; 2022 Oct; 35(10):e15758. PubMed ID: 35945107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis.
    Ramasamy S; Subbian S
    Clin Microbiol Rev; 2021 Jun; 34(3):. PubMed ID: 33980688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms.
    Criado PR; Abdalla BMZ; de Assis IC; van Blarcum de Graaff Mello C; Caputo GC; Vieira IC
    Inflamm Res; 2020 Aug; 69(8):745-756. PubMed ID: 32488318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutaneous manifestation during COVID-19 pandemic.
    Galli E; Cipriani F; Ricci G; Maiello N
    Pediatr Allergy Immunol; 2020 Nov; 31 Suppl 26(Suppl 26):89-91. PubMed ID: 33236439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From SARS-CoV-2 hematogenous spreading to endothelial dysfunction: clinical-histopathological study of cutaneous signs of COVID-19.
    Patrì A; Vargas M; Buonanno P; Annunziata MC; Russo D; Staibano S; Servillo G; Fabbrocini G
    Diagn Pathol; 2021 Feb; 16(1):16. PubMed ID: 33632250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinically Suspected Myocarditis in the Course of Severe Acute Respiratory Syndrome Novel Coronavirus-2 Infection: Fact or Fiction?
    Ozieranski K; Tyminska A; Jonik S; Marcolongo R; Baritussio A; Grabowski M; Filipiak KJ; Opolski G; Caforio ALP
    J Card Fail; 2021 Jan; 27(1):92-96. PubMed ID: 33166657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microvascular Skin Manifestations Caused by COVID-19.
    Gawaz A; Guenova E
    Hamostaseologie; 2021 Oct; 41(5):387-396. PubMed ID: 34695855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous manifestations of SARS-CoV-2 infection: a clinical update.
    Gisondi P; PIaserico S; Bordin C; Alaibac M; Girolomoni G; Naldi L
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2499-2504. PubMed ID: 32585074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and histopathological findings of cutaneous manifestations of COVID-19 patients.
    Brandão MGSA; Barros LM; de Aquino Mendonça J; de Oliveira AR; de Araújo TM; Veras VS
    Dermatol Ther; 2020 Nov; 33(6):e13926. PubMed ID: 32779817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection?
    Mondal R; Lahiri D; Deb S; Bandyopadhyay D; Shome G; Sarkar S; Paria SR; Thakurta TG; Singla P; Biswas SC
    J Thromb Thrombolysis; 2020 Oct; 50(3):567-579. PubMed ID: 32627126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lessons From the First Wave of the Pandemic: Skin Features of COVID-19 Can Be Divided Into Inflammatory and Vascular Patterns [Formula: see text].
    Naderi-Azad S; Vender R
    J Cutan Med Surg; 2021; 25(2):169-176. PubMed ID: 33179534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous Manifestations of SARS-CoV-2 Infection.
    Huynh T; Sanchez-Flores X; Yau J; Huang JT
    Am J Clin Dermatol; 2022 May; 23(3):277-286. PubMed ID: 35247198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cutaneous Manifestations Associated with COVID-19: A Narrative Review].
    Relvas M; Calvão J; Oliveira R; Cardoso JC; Gonçalo M
    Acta Med Port; 2021 Feb; 34(2):128-136. PubMed ID: 33315008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathologic correlations of COVID-19-related cutaneous manifestations with special emphasis on histopathologic patterns.
    Rongioletti F; Ferreli C; Sena P; Caputo V; Atzori L
    Clin Dermatol; 2021; 39(1):149-162. PubMed ID: 33972045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Etiology of Acute Kidney Injury (AKI).
    Chong WH; Saha BK
    Am J Med Sci; 2021 Mar; 361(3):287-296. PubMed ID: 33358501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cutaneous manifestations in children with SARS-CoV-2 infection and/or COVID-19: what do we know after 10 months under this pandemic?
    Li H; Zhao Y; Zhou L
    Int J Dermatol; 2022 Jan; 61(1):39-45. PubMed ID: 34530491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutaneous manifestations of COVID-19.
    Wang CJ; Worswick S
    Dermatol Online J; 2021 Jan; 27(1):. PubMed ID: 33560783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID-19-Mechanisms and Therapeutic Targets.
    Fodor A; Tiperciuc B; Login C; Orasan OH; Lazar AL; Buchman C; Hanghicel P; Sitar-Taut A; Suharoschi R; Vulturar R; Cozma A
    Oxid Med Cell Longev; 2021; 2021():8671713. PubMed ID: 34457119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection.
    El Hachem M; Diociaiuti A; Concato C; Carsetti R; Carnevale C; Ciofi Degli Atti M; Giovannelli L; Latella E; Porzio O; Rossi S; Stracuzzi A; Zaffina S; Onetti Muda A; Zambruno G; Alaggio R
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2620-2629. PubMed ID: 32474947
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 80.